SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-24-000015
Filing Date
2024-08-08
Accepted
2024-08-08 07:42:04
Documents
64
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q carm-20240630.htm   iXBRL 10-Q 1366778
2 EX-31.1 carm-20240630xexx311.htm EX-31.1 10677
3 EX-31.2 carm-20240630xexx312.htm EX-31.2 10674
4 EX-32.1 carm-20240630xexx321.htm EX-32.1 4987
5 EX-32.2 carm-20240630xexx322.htm EX-32.2 4982
  Complete submission text file 0001485003-24-000015.txt   5508062

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT carm-20240630.xsd EX-101.SCH 43282
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT carm-20240630_cal.xml EX-101.CAL 54116
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT carm-20240630_def.xml EX-101.DEF 115817
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT carm-20240630_lab.xml EX-101.LAB 570127
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT carm-20240630_pre.xml EX-101.PRE 352585
67 EXTRACTED XBRL INSTANCE DOCUMENT carm-20240630_htm.xml XML 478298
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 241186092
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)